Abstract:The high risk of tumor recurrence presents a big challenge in melanoma therapy. Photothermal therapy (PIT) has merged as a powerful weapon against tumor in recent years, which produces tumor-associated antigens (TAA) and recruits dendritic cells (DCs) to tumor sites through immunogenic cell death (ICD) for immune activation. However, due to the lack of activation signals of DCs, the immune effect induced by PIT is not sufficient to inhibit the recurrence and proliferation of tumor. To efficiently cooperate PIT and immunotherapy to circumvent tumor recurrence, here we constructed a polydopamine (PDA) based core-shell nanoplatform loading CpG ODNs to elicit robust photothermal ablation and antitumor immune responses. Cationized polydopamine coated with hyaluronic acid (HA) shell was proven an efficient photothermal agent that increased the surface temperature of tumor by 16 degrees C and induced ICD. CpG ODNs effectively induced maturation of DCs by elevating the expression of co-stimulating markers. PIT combined with CpG ODNs achieved a remarkable synergistic treatment effect in the maturation of DCs and activation of T cells in melanoma-bearing mice model compared with PIT or CpG ODNs alone. Furthermore, in a tumor recurrence model, photothermal-immune combination therapy increased the infiltration of CTLs in distant tumor compared with PIT or CpG ODNs alone. The combination therapy overcame insufficient immunity at distant tumor caused by PIT alone and relieved immunosuppression microenvironment of the tumor. Hence, the PDA based core-shell nanoplatform presents a potent photoimmunotherapy against proliferation and recurrence of melanoma. Statement of significance In order to solve the insufficient immunity induced by photothermal therapy (PIT), CpG ODNs were utilized to enhance the weak immune response mediated by PIT through inducing DCs maturation. Hence, we designed a polydopamine (PDA) based core-shell nanoplatform loading CpG ODNs followed by hyaluronic acid named PPP/CpG/HA to elicit robust photothermal ablation and antitumor immune responses. CpG ODNs were delivered to the tumor site through the targeting effect of the HA shell. The core-shell nanoplatform achieved a remarkable synergistic treatment effect in the maturation of DCs and activation of T cells, thereby overcoming insufficient immunity at distant tumor caused by PIT alone. The core-shell nanoplatform presents a potent photo-immunotherapy against proliferation and recurrence of melanoma. (C) 2021 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Design of a targeted dual drug delivery system for boosting the efficacy of photoimmunotherapy against melanoma proliferation and metastasis

Enhanced cancer therapy through synergetic photodynamic/immune checkpoint blockade mediated by a liposomal conjugate comprised of porphyrin and IDO inhibitor.

Co-delivery of doxorubicin and epacadostat via heparin coated pH-sensitive liposomes to suppress the lung metastasis of melanoma.

Dual-Sensitive PEG-Sheddable Nanodrug Hierarchically Incorporating PD-L1 Antibody and Zinc Phthalocyanine for Improved Immuno-Photodynamic Therapy

Size/Charge Changeable Acidity‐Responsive Micelleplex for Photodynamic‐Improved PD‐L1 Immunotherapy with Enhanced Tumor Penetration

Photothermal Therapy Mediated by Phase-Transformation Nanoparticles Facilitates Delivery of Anti-Pd1 Antibody and Synergizes with Antitumor Immunotherapy for Melanoma

Acid-Activatable Versatile Micelleplexes for Pd-L1 Blockade Enhanced Cancer Photodynamic Immunotherapy

Sequentially Responsive Peptide Assembling Liposomes Integrating Photosensitizer and Immune Drug for Enhanced Photodynamic/immunotherapy in Skin Melanoma

Polydopamine-based Nanoplatform for Photothermal Ablation with Long-Term Immune Activation Against Melanoma and Its Recurrence

Activating Antitumor Immunity and Antimetastatic Effect Through Polydopamine-Encapsulated Core-Shell Upconversion Nanoparticles

Precision Delivery of Dual Immune Inhibitors Loaded Nanomodulator to Reverse Immune Suppression for Combinational Photothermal-Immunotherapy

Full‐active Pharmaceutical Ingredient Nanosensitizer for Augmented Photoimmunotherapy by Synergistic Mitochondria Targeting and Immunogenic Death Inducing

Dual‐Targeting Photosensitizer‐Peptide Amphiphile Conjugate for Enzyme‐Triggered Drug Delivery and Synergistic Chemo‐Photodynamic Tumor Therapy

Combination of PEG-decorated Black Phosphorus Nanosheets and Immunoadjuvant for Photoimmunotherapy of Melanoma.

Rational Design of a Robust Antibody-like Small-Molecule Inhibitor Nanoplatform for Enhanced Photoimmunotherapy

A Dual Functional Drug Delivery System That Combines Photothermal Therapy and Immunotherapy to Treat Tumors.

Harnessing Dual Phototherapy and Immune Activation for Cancer Treatment: the Development and Application of BODIPY@F127 Nanoparticles.

Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy

Dual-responsive supramolecular photodynamic nanomedicine with activatable immunomodulation for enhanced antitumor therapy

A Triple-Stimulus Responsive Melanin-Based Nanoplatform with an Aggregation-Induced Emission-Active Photosensitiser for Imaging-Guided Targeted Synergistic Phototherapy/hypoxia-Activated Chemotherapy.

Melanin-loaded biocompatible photosensitive nanoparticles for controlled drug release in combined photothermal-chemotherapy guided by photoacoustic/ultrasound dual-modality imaging